<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK114459" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK114459/" /><meta name="ncbi_pagename" content="ANO5 Muscle Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ANO5 Muscle Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ANO5 Muscle Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/08/22" /><meta name="citation_author" content="Sini Penttilä" /><meta name="citation_author" content="Anna Vihola" /><meta name="citation_author" content="Johanna Palmio" /><meta name="citation_author" content="Bjarne Udd" /><meta name="citation_pmid" content="23193613" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK114459/" /><meta name="citation_keywords" content="Anoctaminopathy" /><meta name="citation_keywords" content="Anoctaminopathy" /><meta name="citation_keywords" content="Miyoshi Muscular Dystrophy 3" /><meta name="citation_keywords" content="Limb-Girdle Muscular Dystrophy Type 2L" /><meta name="citation_keywords" content="Anoctamin-5" /><meta name="citation_keywords" content="ANO5" /><meta name="citation_keywords" content="ANO5 Muscle Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ANO5 Muscle Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Sini Penttilä" /><meta name="DC.Contributor" content="Anna Vihola" /><meta name="DC.Contributor" content="Johanna Palmio" /><meta name="DC.Contributor" content="Bjarne Udd" /><meta name="DC.Date" content="2019/08/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK114459/" /><meta name="description" content="The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal." /><meta name="og:title" content="ANO5 Muscle Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK114459/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ano5-md/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK114459/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D2740E03FDB4100000000075C02AD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK114459_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK114459_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ankrd26/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ap4-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK114459_"><span class="title" itemprop="name"><i>ANO5</i> Muscle Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Anoctaminopathy</div><p class="contrib-group"><span itemprop="author">Sini Penttil&#x000e4;</span>, PhD, <span itemprop="author">Anna Vihola</span>, PhD, <span itemprop="author">Johanna Palmio</span>, MD, PhD, and <span itemprop="author">Bjarne Udd</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK114459_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK114459_ai__"><div class="contrib half_rhythm"><span itemprop="author">Sini Penttil&#x000e4;</span>, PhD<div class="affiliation small">Neuromuscular Research Center<br />Department of Genetics<br />Fimlab Laboratories<br />Tampere, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.balmif@alittnep.inis" class="oemail">if.balmif@alittnep.inis</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anna Vihola</span>, PhD<div class="affiliation small">Neuromuscular Research Center<br />Department of Genetics<br />Fimlab Laboratories<br />Tampere, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.iknisleh@alohiv.anna" class="oemail">if.iknisleh@alohiv.anna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Johanna Palmio</span>, MD, PhD<div class="affiliation small">Neuromuscular Research Center<br />Tampere University and University Hospital<br />Tampere, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.inut@oimlap.annahoj" class="oemail">if.inut@oimlap.annahoj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bjarne Udd</span>, MD, PhD<div class="affiliation small">Neuromuscular Research Center<br />Tampere University and University Hospital<br />Tampere, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.phsp@ddu.enrajb" class="oemail">if.phsp@ddu.enrajb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 29, 2012</span>; Last Update: <span itemprop="dateModified">August 22, 2019</span>.</p><p><em>Estimated reading time: 13 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ano5-md.Summary" itemprop="description"><h2 id="_ano5-md_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The spectrum of <i>ANO5</i> muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>ANO5</i> muscle disease is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ANO5</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a><i>.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> No definitive treatments for the limb-girdle muscular dystrophies exist. Management is tailored to the individual. To assist with decreased mobility, the following are suggested: weight control to avoid obesity, physical therapy to promote mobility and prevent contractures, and use of mechanical aids to help ambulation and mobility.</p><p><i>Surveillance:</i> Evaluate muscle strength and functional status every six to 12 months.</p><p><i>Agents/circumstances to avoid:</i> Heavy muscle force training of weak muscles. The use of statins, which can induce muscle pain and worsen muscle weakness should be avoided, but if absolutely necessary for the health of the individual, use requires extra monitoring of clinical status especially at the beginning of treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ANO5</i> muscle disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk and preimplantation diagnosis are possible if the pathogenic variants in the family have been identified.</p></div></div><div id="ano5-md.GeneReview_Scope"><h2 id="_ano5-md_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="ano5-md.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ano5-md.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>ANO5</i> Muscle Disease: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Limb-girdle muscular dystrophy type 2L</div></li><li class="half_rhythm"><div>Miyoshi muscular dystrophy 3</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#ano5-md.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="ano5-md.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#ano5-md.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="ano5-md.Diagnosis"><h2 id="_ano5-md_Diagnosis_">Diagnosis</h2><div id="ano5-md.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>ANO5</i> muscle disease <b>should be suspected</b> in individuals with any of the following presentations:</p><ul><li class="half_rhythm"><div>Late-adult-onset proximal lower-limb weakness (known as limb-girdle muscular dystrophy type 2L (LGMD2L)</div><ul><li class="half_rhythm"><div>Mean onset age 35 years; range 15-70 years</div></li><li class="half_rhythm"><div>Asymmetric muscle weakness and atrophy, especially in thigh muscles</div></li></ul></li><li class="half_rhythm"><div>Early-adult-onset (age 20-25 years) calf distal myopathy (known as Miyoshi muscular dystrophy 3)</div></li><li class="half_rhythm"><div>Asymptomatic hyperCKemia and exercise-induced myalgia</div></li></ul><p>In all presentations:</p><ul><li class="half_rhythm"><div>EMG shows myopathic changes with scattered necrotic fibers or may be normal in mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>CT and MRI show fatty degeneration of the gastrocnemius medialis muscle in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with involvement of the soleus and posterior thigh muscles with disease progression (see <a class="figpopup" href="/books/NBK114459/figure/ano5-md.F2/?report=objectonly" target="object" rid-figpopup="figano5mdF2" rid-ob="figobano5mdF2">Figure 2</a>).</div></li><li class="half_rhythm"><div>Serum CK concentration is markedly elevated (&#x02265;2-3x &#x02013; and usually 10-50x &#x02013; the upper limit of normal)</div></li><li class="half_rhythm"><div>Muscle biopsy shows scattered necrotic fibers or nonspecific myopathic or dystrophic findings</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figano5mdF2" co-legend-rid="figlgndano5mdF2"><a href="/books/NBK114459/figure/ano5-md.F2/?report=objectonly" target="object" title="Figure 2" class="img_link icnblk_img figpopup" rid-figpopup="figano5mdF2" rid-ob="figobano5mdF2"><img class="small-thumb" src="/books/NBK114459/bin/ano5-md-Image002.gif" src-large="/books/NBK114459/bin/ano5-md-Image002.jpg" alt="Figure 2. A." /></a><div class="icnblk_cntnt" id="figlgndano5mdF2"><h4 id="ano5-md.F2"><a href="/books/NBK114459/figure/ano5-md.F2/?report=objectonly" target="object" rid-ob="figobano5mdF2">Figure 2</a></h4><p class="float-caption no_bottom_margin">A. Fatty degenerative changes in posterior thigh muscles in the left vastus medialis and intermedius muscles B. Fatty degenerative changes in the medial gastrocnemius (left greater than right) and in the left soleus muscle</p></div></div></div><div id="ano5-md.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>ANO5</i> muscle disease <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ANO5</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK114459/table/ano5-md.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figano5mdTmoleculargenetictestingused" rid-ob="figobano5mdTmoleculargenetictestingused">Table 1</a>).</p><p>Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>ANO5</i> muscle disease is indistinguishable from many other inherited muscle disorders, recommended <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> or <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>ANO5</i>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><ul><li class="half_rhythm"><div class="half_rhythm">A muscle disease <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ANO5</i> and other genes of interest (see <a href="#ano5-md.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is recommended (see <a class="figpopup" href="/books/NBK114459/table/ano5-md.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figano5mdTmoleculargenetictestingused" rid-ob="figobano5mdTmoleculargenetictestingused">Table 1</a>). Note: To date such variants have not been identified as a cause of <i>ANO5</i> muscle disease.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is another good option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</div><div class="half_rhythm">If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. Note: To date such variants have not been identified as a cause of <i>ANO5</i> muscle disease.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="ano5-md.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ANO5</i> Muscle Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANO5</i></td><td headers="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4,</sup>&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_ano5-md.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ano5-md.TF.1.1"><p class="no_margin">See <a href="/books/NBK114459/#ano5-md.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ano5-md.TF.1.2"><p class="no_margin">See Molecular Genetics for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="ano5-md.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="ano5-md.TF.1.4"><p class="no_margin">The most common pathogenic variants in northern European populations are c.191dupA in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5 and c.2272C&#x0003e;T in exon 20.</p></div></dd><dt>5. </dt><dd><div id="ano5-md.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#ano5-md.REF.ten_dam.2019.126">Ten Dam et al [2019]</a></p></div></dd><dt>6. </dt><dd><div id="ano5-md.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="ano5-md.Clinical_Characteristics"><h2 id="_ano5-md_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ano5-md.Clinical_Description"><h3>Clinical Description</h3><p>The spectrum of <i>ANO5</i> muscle disease is a continuum ranging from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is late-onset proximal lower-limb weakness (also called limb-girdle muscular dystrophy type 2L or LGMD2) [<a class="bk_pop" href="#ano5-md.REF.bolduc.2010.213">Bolduc et al 2010</a>, <a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al 2011</a>, <a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>] (<a class="figpopup" href="/books/NBK114459/table/ano5-md.T.the_lgmd2l_phenotype_of_the_fi/?report=objectonly" target="object" rid-figpopup="figano5mdTthelgmd2lphenotypeofthefi" rid-ob="figobano5mdTthelgmd2lphenotypeofthefi">Table 2</a>). Less common is early-adult-onset calf distal myopathy (also called Miyoshi muscular dystrophy 3) [<a class="bk_pop" href="#ano5-md.REF.mahjneh.2010.791">Mahjneh et al 2010</a>, <a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al 2011</a>, <a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>].</p><p><b>Presentation.</b> Onset of the proximal weakness in the limb-girdle muscular dystrophy (LGMD) form is in the fourth or fifth decade (age range 15-70 years); onset of calf weakness in the distal form is around age 20 years. Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles [<a class="bk_pop" href="#ano5-md.REF.bolduc.2010.213">Bolduc et al 2010</a>, <a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al 2011</a>, <a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>, <a class="bk_pop" href="#ano5-md.REF.papadopoulos.2017.1096">Papadopoulos et al 2017</a>, <a class="bk_pop" href="#ano5-md.REF.ten_dam.2019.126">Ten Dam et al 2019</a>].</p><ul><li class="half_rhythm"><div>In the limb-girdle muscular dystrophy form, muscle weakness is mainly proximal and more pronounced in the lower limbs; however, many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals also have proximal upper-limb involvement.</div></li><li class="half_rhythm"><div>In the distal myopathy form, calf hypertrophy and exercise myalgia can occur before apparent weakness and later calf atrophy. Clinical manifestations can be mild or subjectively nonexistent even with clear changes observed on muscle imaging. Individuals with distal onset may have proximal lower-limb weakness in the later stages of the disease. Distal upper-limb weakness has not been reported.</div></li><li class="half_rhythm"><div>Muscle weakness and atrophy are frequently asymmetric (see <a class="figpopup" href="/books/NBK114459/figure/ano5-md.F1/?report=objectonly" target="object" rid-figpopup="figano5mdF1" rid-ob="figobano5mdF1">Figure 1</a>).</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figano5mdF1" co-legend-rid="figlgndano5mdF1"><a href="/books/NBK114459/figure/ano5-md.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figano5mdF1" rid-ob="figobano5mdF1"><img class="small-thumb" src="/books/NBK114459/bin/ano5-md-Image001.gif" src-large="/books/NBK114459/bin/ano5-md-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndano5mdF1"><h4 id="ano5-md.F1"><a href="/books/NBK114459/figure/ano5-md.F1/?report=objectonly" target="object" rid-ob="figobano5mdF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Asymmetric atrophy of the muscles of the left calf in an individual with an ANO5 pathogenic variant </p></div></div><div id="ano5-md.T.the_lgmd2l_phenotype_of_the_fi" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>The LGMD2L Phenotype of the first 20 reported individuals</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.the_lgmd2l_phenotype_of_the_fi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.the_lgmd2l_phenotype_of_the_fi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Characteristic</th><th id="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># of Individuals</th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased creatine kinase value (&#x0003e;10x)</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proximal lower-limb weakness</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Adult onset (&#x0003e;20 years)</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Muscle atrophy</b></td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>19/20</b></td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Quadriceps/hamstrings</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Calf</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14 (8&#x000a0;<sup>1</sup>) /20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Quadriceps/hamstrings and calf</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Upper-limb (mainly biceps)</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Asymmetry of muscle weakness or atrophy</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Distal lower-limb weakness</b></td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>17/20</b></td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Mild</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">13/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Moderate to severe</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Upper-limb proximal weakness</b></td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>13/20</b></td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Mild</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Moderate to severe</div></li></ul>
</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Good sports performance in presymptomatic period</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Knee hyperextension</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scapular winging</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Restriction/loss of ambulation</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Contractures</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/20</td></tr><tr><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myoglobinuria</td><td headers="hd_h_ano5-md.T.the_lgmd2l_phenotype_of_the_fi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3/20</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">From <a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al [2011]</a></p></div></dd><dt>1. </dt><dd><div id="ano5-md.TF.2.1"><p class="no_margin">Medial part</p></div></dd></dl></div></div></div><p><b>Cardiac findings.</b> In 19 individuals with <i>ANO5</i> muscle disease who underwent systematic cardiac investigations, two had dilated cardiomyopathy at age &#x02264;42 years and three had left ventricular dilatation [<a class="bk_pop" href="#ano5-md.REF.wahbi.2013.76">Wahbi et al 2013</a>]. Rarely, other individuals have been reported with arrhythmias [<a class="bk_pop" href="#ano5-md.REF.witting.2013.2084">Witting et al 2013</a>, <a class="bk_pop" href="#ano5-md.REF.ten_dam.2019.126">Ten Dam et al 2019</a>], hypertrophic cardiomyopathy [<a class="bk_pop" href="#ano5-md.REF.van_der_kooi.2013.456">van der Kooi et al 2013</a>], or left ventricular dysfunction [<a class="bk_pop" href="#ano5-md.REF.ten_dam.2019.126">Ten Dam et al 2019</a>].</p><p><b>Other.</b> Bulbar or respiratory symptoms have not been reported.</p><p><b>Gender differences.</b> Females tend to have milder disease manifestations than males [<a class="bk_pop" href="#ano5-md.REF.bolduc.2010.213">Bolduc et al 2010</a>, <a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al 2011</a>, <a class="bk_pop" href="#ano5-md.REF.magri.2012.934">Magri et al 2012</a>, <a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>, <a class="bk_pop" href="#ano5-md.REF.sarkozy.2013.1111">Sarkozy et al 2013</a>, <a class="bk_pop" href="#ano5-md.REF.van_der_kooi.2013.456">van der Kooi et al 2013</a>]. It is possible females are underrepresented in the reports due to milder disease course, which may be only hyperCKemia with or without myalgia or mild muscle weakness.</p><p><b>Progression and life span</b>. Disease progression is slow in both the LGMD and distal form; ambulation is preserved until very late in the disease course. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals remain ambulatory without assistance for decades. Life span appears to be normal.</p></div><div id="ano5-md.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> for <i>ANO5</i> have been identified [<a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>].</p></div><div id="ano5-md.Nomenclature"><h3>Nomenclature</h3><p>Miyoshi muscular dystrophy 3 may also be referred to as non-dysferlin Miyoshi muscular dystrophy or MMD3.</p></div><div id="ano5-md.Prevalence"><h3>Prevalence</h3><p><i>ANO5</i> muscle disease has been estimated to be one of the most common causes of limb-girdle muscular dystrophy. Prevalence in Finland is as high as 2:100,000 [<a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>]; in the North of England it has been estimated at 0.26:100,000 [<a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al 2011</a>]. In Europe, <i>ANO5</i> muscle disease has been estimated to be the third most prevalent LGMD subtype (26%) although this may be an underestimation due to the less severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#ano5-md.REF.ten_dam.2019.126">Ten Dam et al 2019</a>]. In a large cohort study of 4656 individuals with clinically suspected LGMD across the US, <i>ANO5</i> was the fourth most prevalent LGMD subtype (7%) [<a class="bk_pop" href="#ano5-md.REF.nallamilli.2018.1574">Nallamilli et al 2018</a>].</p></div></div><div id="ano5-md.Genetically_Related_Allelic_Diso"><h2 id="_ano5-md_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>Dominant pathogenic variants in <i>ANO5</i> are known to cause gnathodiaphyseal dysplasia (OMIM <a href="https://omim.org/entry/166260" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">166260</a>), a generalized skeletal syndrome characterized by cemento-osseus lesions of the jawbones, in conjunction with bone fragility, bowing/cortical thickening of tubular bones, and diaphyseal sclerosis of long bones. The functional difference between dominant and recessive ANO5 pathogenic variants is not understood. However, dominant <i>ANO5</i> variants appear to locate in an extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> following the first transmembrane domain or in the fourth putative transmembrane domain [<a class="bk_pop" href="#ano5-md.REF.jin.2017.40935">Jin et al 2017</a>]. Recessive <i>ANO5</i> variants have been shown to decrease the ANO5 protein expression [<a class="bk_pop" href="#ano5-md.REF.vihola.2018.441">Vihola et al 2018</a>].</p></div><div id="ano5-md.Differential_Diagnosis"><h2 id="_ano5-md_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Limb-girdle muscular dystrophy (LGMD).</b> The differential diagnosis of <i>ANO5</i> muscle disease includes all the LGMDs (see OMIM phenotypic series: <a href="https://omim.org/phenotypicSeries/PS253600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LGMD, autosomal recessive</a> and <a href="https://omim.org/phenotypicSeries/PS603511" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LGMD, autosomal dominant</a>). Of particular note is LGMD2B with primarily proximal weakness. LGMD2B is a <a href="/books/n/gene/miyoshi/">dysferlinopathy</a> characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression.</p><p><b>Distal myopathy.</b> Muscle MRI, muscle pathology, and <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> may be useful in distinguishing between distal myopathies in the differential diagnosis of <i>ANO5</i> muscle disease (see <a class="figpopup" href="/books/NBK114459/table/ano5-md.T.genes_associated_with_distal_m/?report=objectonly" target="object" rid-figpopup="figano5mdTgenesassociatedwithdistalm" rid-ob="figobano5mdTgenesassociatedwithdistalm">Table 3</a>).</p><div id="ano5-md.T.genes_associated_with_distal_m" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Genes Associated with Distal Myopathies of Interest in the Differential Diagnosis of <i>ANO5</i> Muscle Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.genes_associated_with_distal_m/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.genes_associated_with_distal_m_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mean Onset Age (yrs)</th><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Initial Muscle Group Involved</th><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Serum CK Concentration</th><th id="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle Biopsy</th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b><i>ANO5</i>&#x000a0;<sup>1</sup></b></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miyoshi muscular dystrophy 3</b></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>AR</b></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>20-25</b></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Asymmetric posterior compartment in legs</b></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x0003e;10x</b></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Myopathic changes; scattered necrotic &#x0fb01;bers</b></td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DYSF</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Miyoshi myopathy&#x000a0;<sup>2</sup> (see <a href="/books/n/gene/miyoshi/">Dysferlinopathy</a>)</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19 (median age at onset)</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior compartment in legs</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;10x</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myopathic changes</td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNE</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ibm/">Nonaka distal myopathy</a></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15-20</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anterior compartment in legs</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;10x</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rimmed vacuoles</td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LDB3</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Zaspopathy&#x000a0;<sup>3</sup> (OMIM <a href="https://omim.org/entry/609452" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609452</a>)</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anterior compartment in legs</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal or slightly &#x02191;</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vacuolar &#x00026; myofibrillar myopathy</td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYH7</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mpd1/">Laing distal myopathy</a></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anterior compartment in legs &#x00026; neck flexors</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to (rarely) moderately &#x02191;</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Type 1 fiber atrophy in tibial anterior muscles; disproportion in proximal muscles</td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYOT</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distal myotilinopathy (OMIM <a href="https://omim.org/entry/609200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609200</a>)</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior &#x0003e; anterior in legs</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slightly &#x02191;</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vacuolar &#x00026; myofibrillar</td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TIA1</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Welander distal myopathy (OMIM <a href="https://omim.org/entry/604454" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604454</a>)</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distal upper limbs (finger &#x00026; wrist extensors)</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal or slightly &#x02191;</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rimmed vacuoles</td></tr><tr><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTN</i></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/udd/">Udd distal myopathy</a></td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anterior compartment in legs</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal or slightly &#x02191;</td><td headers="hd_h_ano5-md.T.genes_associated_with_distal_m_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; rimmed vacuoles</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CK = creatine kinase; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="ano5-md.TF.3.1"><p class="no_margin">Topic of this <i>GeneReview</i>; included to facilitate quick comparison of disorders</p></div></dd><dt>2. </dt><dd><div id="ano5-md.TF.3.2"><p class="no_margin">Miyoshi myopathy is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles (see <a class="figpopup" href="/books/NBK114459/figure/ano5-md.F2/?report=objectonly" target="object" rid-figpopup="figano5mdF2" rid-ob="figobano5mdF2">Figure 2</a>). The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared.</p></div></dd><dt>3. </dt><dd><div id="ano5-md.TF.3.3"><p class="no_margin">Zaspopathy may also be referred to as Markesbery-Griggs late-onset distal myopathy.</p></div></dd></dl></div></div></div></div><div id="ano5-md.Management"><h2 id="_ano5-md_Management_">Management</h2><div id="ano5-md.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with <i>ANO5</i> muscle disease, the evaluations summarized in <a class="figpopup" href="/books/NBK114459/table/ano5-md.T.recommended_evaluations_follow/?report=objectonly" target="object" rid-figpopup="figano5mdTrecommendedevaluationsfollow" rid-ob="figobano5mdTrecommendedevaluationsfollow">Table 4</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="ano5-md.T.recommended_evaluations_follow" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>ANO5</i> Muscle Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.recommended_evaluations_follow/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.recommended_evaluations_follow_lrgtbl__"><table><thead><tr><th id="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuromuscular</b></td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation &#x00026; manual muscle force measurement</td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To establish a baseline for future assessment of disease progression &#x00026; possible need for assistive devices</td></tr><tr><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Muscle imaging (CT or MRI)</td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To identify the pattern of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> muscles in detail</td></tr><tr><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baseline cardiac evaluation</td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_ano5-md.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="ano5-md.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No definitive treatments for the limb-girdle muscular dystrophies exist. Management is tailored to each individual and each specific subtype.</p><div id="ano5-md.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>ANO5</i> Muscle Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.treatment_of_manifestations_in_lrgtbl__"><table><thead><tr><th id="hd_h_ano5-md.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_ano5-md.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_ano5-md.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/<br />Other</th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Decreased mobility</b></td><td headers="hd_h_ano5-md.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Weight control to avoid obesity</div></li><li class="half_rhythm"><div>Physical therapy to promote mobility &#x00026; prevent contractures</div></li><li class="half_rhythm"><div>Mechanical aids to help ambulation &#x00026; mobility</div></li></ul>
</td><td headers="hd_h_ano5-md.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="ano5-md.Surveillance"><h3>Surveillance</h3><div id="ano5-md.T.recommended_surveillance_for_i" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>ANO5</i> Muscle Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.recommended_surveillance_for_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.recommended_surveillance_for_i_lrgtbl__"><table><tbody><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>System/Concern</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Evaluation</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Frequency</b></td></tr><tr><td scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neuromuscular</b></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate muscle strength &#x00026;functional status</td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6-12 mos</td></tr></tbody></table></div></div></div><div id="ano5-md.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Heavy muscle force training of weak muscles should be avoided as very high levels of CK have been measured after strenuous exercise [<a class="bk_pop" href="#ano5-md.REF.milone.2012.13">Milone et al 2012</a>, <a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>].</p><p>The use of statins, which can induce muscle pain and worsen muscle weakness should be avoided. If absolutely necessary for the health of the individual, statin use requires extra monitoring of clinical status especially at the beginning of treatment.</p></div><div id="ano5-md.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ano5-md.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ano5-md.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="ano5-md.Genetic_Counseling"><h2 id="_ano5-md_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ano5-md.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ANO5</i> muscle disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ano5-md.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>ANO5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing an <i>ANO5</i> muscle disease.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing an <i>ANO5</i> muscle disease.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with an <i>ANO5</i> muscle disease are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ANO5</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="ano5-md.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ANO5</i> pathogenic variants in the family.</p></div><div id="ano5-md.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ano5-md.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ANO5</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="ano5-md.Resources"><h2 id="_ano5-md_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Genetic and Rare Diseases Information Center (GARD)</b></div><div>PO Box 8126</div><div>Gaithersburg MD 20898-8126</div><div><b>Phone:</b> 888-205-2311 (toll-free); 888-205-3223 (toll-free TTY)</div><div><b>Fax:</b> 301-251-4911</div><div><b>Email:</b> GARDinfo@nih.gov</div><div><a href="http://rarediseases.info.nih.gov/GARD/QnASelected.aspx?diseaseID=6907" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Limb-Girdle Muscular Dystrophy</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - Canada</b></div><div>2345 Yonge Street</div><div>Suite 900</div><div>Toronto Ontario M4P 2E5</div><div>Canada</div><div><b>Phone:</b> 866-687-2538 (toll-free); 416-488-0030</div><div><b>Fax:</b> 416-488-7523</div><div><b>Email:</b> info@muscle.ca</div><div><a href="http://www.muscle.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.muscle.ca</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li></ul></div><div id="ano5-md.Molecular_Genetics"><h2 id="_ano5-md_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ano5-md.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ANO5 Muscle Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ano5-md.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ano5-md.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ano5-md.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ano5-md.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ano5-md.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ano5-md.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ano5-md.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/203859" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ANO5</i></a></td><td headers="hd_b_ano5-md.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=203859" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p14<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ano5-md.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q75V66" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Anoctamin-5</a></td><td headers="hd_b_ano5-md.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/ANO5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANO5 @LOVD</a></td><td headers="hd_b_ano5-md.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ANO5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANO5</a></td><td headers="hd_b_ano5-md.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ANO5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ANO5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ano5-md.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ano5-md.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ANO5 Muscle Disease (<a href="/omim/608662,611307,613319" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608662" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608662</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ANOCTAMIN 5; ANO5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611307" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611307</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613319" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613319</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MIYOSHI MUSCULAR DYSTROPHY 3; MMD3</td></tr></tbody></table></div></div><div id="ano5-md.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>ANO5 (anoctamin 5) belongs to a protein family of Ca<sup>2+</sup> activated ion channels and phospholipid scramblases. However, not much is known about its normal function and also the molecular pathogenesis is so far not understood. According to a recent study, it appears that ANO5 deficiency compromises the plasma membrane repair ability of myoblasts [<a class="bk_pop" href="#ano5-md.REF.chandra.2019.118">Chandra et al 2019</a>].</p><p><b>Mechanism of disease causation.</b> It seems likely that the main disease mechanism in anoctaminopathy is loss of function. This is based on the observation that in most cases, regardless of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (truncating or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>), the ANO5 protein is clearly reduced in biopsies of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b><i>ANO5-</i>specific laboratory technical considerations.</b> A western blotting method has been developed to detect endogenous ANO5 protein in membrane fractions extracted from human muscle biopsies. This method can be used to quantify the ANO5 protein and evaluate the pathogenicity of novel <i>ANO5</i> variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>.</p><div id="ano5-md.T.notable_ano5_pathogenic_varian" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Notable <i>ANO5</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK114459/table/ano5-md.T.notable_ano5_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ano5-md.T.notable_ano5_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_213599.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_213599<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_998764.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_998764<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.191dupA</td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn64LysfsTer15</td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common in northern European populations [<a class="bk_pop" href="#ano5-md.REF.hicks.2011.171">Hicks et al 2011</a>, <a class="bk_pop" href="#ano5-md.REF.nallamilli.2018.1574">Nallamilli et al 2018</a>]</td></tr><tr><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.2272C&#x0003e;T</td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg758Cys</td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common in northern European populations [<a class="bk_pop" href="#ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; et al 2012</a>]</td></tr><tr><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1898+1G&#x0003e;A</td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met470LeufsTer16</td><td headers="hd_h_ano5-md.T.notable_ano5_pathogenic_varian_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Founder variant in the Netherlands [<a class="bk_pop" href="#ano5-md.REF.nallamilli.2018.1574">Nallamilli et al 2018</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div></div><div id="ano5-md.References"><h2 id="_ano5-md_References_">References</h2><div id="ano5-md.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.bolduc.2010.213">Bolduc V, Marlow G, Boycott KM, Saleki K, Inoue H, Kroon J, Itakura M, Robitaille Y, Parent L, Baas F, Mizuta K, Kamata N, Richard I, Linssen WHJP, Mahjneh I, de Visser M, Bashir R, Brais B. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">86</span>:213–21.</span> [<a href="/pmc/articles/PMC2820170/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2820170</span></a>] [<a href="/pubmed/20096397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20096397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.chandra.2019.118">Chandra G, Defour A, Mamchoui K, Pandey K, Mishra S, Mouly V, Sreetama S, Mahad Ahmad M, Mahjneh I, Morizono H, Pattabiraman N, Menon AK, Jaiswal JK. Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells. <span><span class="ref-journal">Cell Death Discov. </span>2019;<span class="ref-vol">5</span>:118.</span> [<a href="/pmc/articles/PMC6639303/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6639303</span></a>] [<a href="/pubmed/31341644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31341644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.hicks.2011.171">Hicks D, Sarkozy A, Muelas N, Koehler K, Huebner A, Hudson G, Chinnery PF, Barresi R, Eagle M, Polvikoski T, Bailey G, Miller J, Radunovic A, Hughes PJ, Roberts R, Krause S, Walter MC, Laval SH, Straub V, Lochm&#x000fc;ller H, Bushby K. A founder mutation in anoctamin 5 is a major cause of limb-girdle muscular dystrophy. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:171–82.</span> [<a href="/pmc/articles/PMC4038512/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4038512</span></a>] [<a href="/pubmed/21186264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21186264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.jin.2017.40935">Jin L, Liu Y, Sun F, Collins MT, Blackwell K, Woo AS, Reichenberger EJ, Hu Y. Three novel ANO5 missense mutations in Caucasian and Chinese families and sporadic cases with gnathodiaphyseal dysplasia. <span><span class="ref-journal">Sci Rep. </span>2017;<span class="ref-vol">7</span>:40935.</span> [<a href="/pmc/articles/PMC5296836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5296836</span></a>] [<a href="/pubmed/28176803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28176803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.magri.2012.934">Magri F, Bo RD, D'Angelo MG, Sciacco M, Gandossini S, Govoni A, Napoli L, Ciscato P, Fortunato F, Brighina E, Bonato S, Bordoni A, Lucchini V, Corti S, Moggio M, Bresolin N, Comi GP. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients. <span><span class="ref-journal">Neuromuscul Disord. </span>2012;<span class="ref-vol">22</span>:934–43.</span> [<a href="/pmc/articles/PMC3500692/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3500692</span></a>] [<a href="/pubmed/22742934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22742934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.mahjneh.2010.791">Mahjneh I, Jaiswal J, Lamminen A, Somer M, Marlow G, Kiuru-Enari S, Bashir R. A new distal myopathy with mutation in anoctamin 5. <span><span class="ref-journal">Neuromuscul Disord. </span>2010;<span class="ref-vol">20</span>:791–5.</span> [<a href="/pmc/articles/PMC4206776/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4206776</span></a>] [<a href="/pubmed/20692837" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20692837</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.milone.2012.13">Milone M, Liewluck T, Winder TL, Pianosi PT. Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. <span><span class="ref-journal">Neuromuscul Disord. </span>2012;<span class="ref-vol">22</span>:13–5.</span> [<a href="/pubmed/21820307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21820307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.nallamilli.2018.1574">Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, da Silva C, Beadling R, Alexander JJ, Askree SH, Whitt Z, Bean L, Collins C, Khadilkar S, Gaitonde P, Dastur R, Wicklund M, Mozaffar T, Harms M, Rufibach L, Mittal P, Hegde M. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. <span><span class="ref-journal">Ann Clin Transl Neurol. </span>2018;<span class="ref-vol">5</span>:1574–87.</span> [<a href="/pmc/articles/PMC6292381/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6292381</span></a>] [<a href="/pubmed/30564623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30564623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.papadopoulos.2017.1096">Papadopoulos C, Lafor&#x000ea;t P, Nectoux J, Stojkovic T, Wahbi K, Carlier RY, Carlier PG, Leonard-Louis S, Leturcq F, Romero N, Eymard B, Behin A. Hyperckemia and myalgia are common presentations of anoctamin-5-related myopathy in French patients. <span><span class="ref-journal">Muscle Nerve. </span>2017;<span class="ref-vol">56</span>:1096–100.</span> [<a href="/pubmed/28187523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28187523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.penttil_.2012.897">Penttil&#x000e4; S, Palmio J, Suominen T, Raheem O, Evil&#x000e4; A, Muelas Gomez N, Tasca G, Waddell LB, Clarke NF, Barboi A, Hackman P, Udd B. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5. <span><span class="ref-journal">Neurology. </span>2012;<span class="ref-vol">78</span>:897–903.</span> [<a href="/pubmed/22402862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22402862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.sarkozy.2013.1111">Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, P&#x000e9;nisson-Besnier I, De Waele L, Turnbull D, Guglieri M, Schrank B, Schoser B, Seeger J, Schreiber H, Gl&#x000e4;ser D, Eagle M, Bailey G, Walters R, Longman C, Norwood F, Winer J, Muntoni F, Hanna M, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Davies NP, Gibson A, Gorman GS, Hammans S, Jackson AP, Khan A, Lane R, McConville J, McEntagart M, Al-Memar A, Nixon J, Panicker J, Parton M, Petty R, Price CJ, Rakowicz W, Ray P, Schapira AH, Swingler R, Turner C, Wagner KR, Maddison P, Shaw PJ, Straub V, Bushby K, Lochm&#x000fc;ller H. ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:1111–8.</span> [<a href="/pubmed/23606453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23606453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.ten_dam.2019.126">Ten Dam L, Frankhuizen WS, Linssen WHJP, Straathof CS, Niks EH, Faber K, Fock A, Kuks JB, Brusse E, de Coo R, Voermans N, Verrips A, Hoogendijk JE, van der Pol L, Westra D, de Visser M, van der Kooi AJ, Ginjaar I. Autosomal recessive limb-girdle and Miyoshi muscular dystrophies in the Netherlands: The clinical and molecular spectrum of 244 patients. <span><span class="ref-journal">Clin Genet. </span>2019;<span class="ref-vol">96</span>:126–33.</span> [<a href="/pubmed/30919934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30919934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.van_der_kooi.2013.456">van der Kooi AJ, Ten Dam L, Frankhuizen WS, Straathof CS, van Doorn PA, de Visser M, Ginjaar IB. ANO5 mutations in the Dutch limb girdle muscular dystrophy population. <span><span class="ref-journal">Neuromuscul Disord. </span>2013;<span class="ref-vol">23</span>:456–60.</span> [<a href="/pubmed/23607914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23607914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.vihola.2018.441">Vihola A, Luque H, Savarese M, Penttil&#x000e4; S, Lindfors M, Leturq F, Eymard B, Tasca G, Brais B, Conte T, Charton K, Richard I, Udd B. Diagnostic anoctamin 5 protein defect in patients with ANO5 mutated muscular dystrophy. <span><span class="ref-journal">Neuropathol Appl Neurobiol. </span>2018;<span class="ref-vol">44</span>:441–8.</span> [<a href="/pubmed/28489263" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28489263</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.wahbi.2013.76">Wahbi K, B&#x000e9;hin A, B&#x000e9;cane HM, Leturcq F, Coss&#x000e9;e M, Lafor&#x000ea;t P, Stojkovic T, Carlier P, Toussaint M, Gaxotte V, Cluzel P, Eymard B, Duboc D. Dilated cardiomyopathy in patients with mutations in anoctamin 5. <span><span class="ref-journal">Int J Cardiol. </span>2013;<span class="ref-vol">168</span>:76–9.</span> [<a href="/pubmed/23041008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23041008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ano5-md.REF.witting.2013.2084">Witting N, Duno M, Petri H, Krag T, Bundgaard H, Kober L, Vissing J. Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression. <span><span class="ref-journal">J Neurol. </span>2013;<span class="ref-vol">260</span>:2084–93.</span> [<a href="/pubmed/23670307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23670307</span></a>]</div></li></ul></div></div><div id="ano5-md.Chapter_Notes"><h2 id="_ano5-md_Chapter_Notes_">Chapter Notes</h2><div id="ano5-md.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 August 2019 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 November 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>19 July 2012 (sp) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK114459</span><span class="label">PMID: <a href="/pubmed/23193613" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">23193613</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ankrd26/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ap4-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK114459&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK114459/?report=reader">PubReader</a></li><li><a href="/books/NBK114459/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK114459" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK114459" style="display:none" title="Cite this Page"><div class="bk_tt">Penttilä S, Vihola A, Palmio J, et al. ANO5 Muscle Disease. 2012 Nov 29 [Updated 2019 Aug 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK114459/pdf/Bookshelf_NBK114459.pdf">PDF version of this page</a> (536K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ano5-md.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ano5-md.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#ano5-md.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ano5-md.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ano5-md.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ano5-md.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ano5-md.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ano5-md.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ano5-md.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ano5-md.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ano5-md.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ano5-md.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=203859[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ANO5</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK114459+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2992724" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2992724" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2992724" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2992724" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301490" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calpainopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Calpainopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Angelini C, Fanin M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301609" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bonne G, Leturcq F, Ben Yaou R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301480" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dysferlinopathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dysferlinopathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Aoki M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301559" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Caveolinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Caveolinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bruno C, Sotgia F, Gazzerro E, Minetti C, Lisanti MP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22675738" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">LAMA2</i>-Related Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">LAMA2</i>-Related Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Quijano-Roy S, Sparks SE, Rutkowski A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=23193613" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=23193613" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0410a9dde08911698e6d94">ANO5 Muscle Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ANO5 Muscle Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:45:13-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D2740E03FDB4100000000075C02AD&amp;ncbi_session=CE8D2740E0410A81_1884SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK114459%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK114459&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK114459/&amp;ncbi_pagename=ANO5 Muscle Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D2740E0410A81_1884SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>